The oxidized‐LDL/LOX‐1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells

Abstract Epidemiological relationships between cancer and cardiovascular diseases have been reported, but a molecular basis remains unclear. Some proteoglycans that strongly bind low‐density‐lipoprotein (LDL) are abundant both in atherosclerotic regions and in high metastatic‐tumor tissue. LDL retention is crucial for the initiation of atherosclerosis, although its contribution to malignancy of cancer is not known. In our study, we show the importance of the accumulation of LDL in tumor metastasis. We demonstrated that high metastatic‐tumor tissue contains high amounts of LDL and forms more oxidized LDL (ox‐LDL). Interestingly, lectin‐like ox‐LDL receptor 1 (LOX‐1), a receptor for ox‐LDL and a recognized key molecule for cardiovascular diseases, was highly expressed in tumor endothelial cells (TECs). Neutrophils are important for ox‐LDL formation. Since we observed the accumulation and activation of neutrophils in HM‐tumors, we evaluated the involvement of LOX‐1 in neutrophil migration and activation. LOX‐1 induced neutrophil migration via CCL2 secretion from TECs, which was enhanced by ox‐LDL. Finally, we show genetic manipulation of LOX‐1 expression in TECs or tumor stroma tended to reduce lung metastasis. Thus, the LOX‐1/ox‐LDL axis in TECs may lead to the formation of a high metastatic‐tumor microenvironment via attracting neutrophils.